{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:06:47Z","timestamp":1785337607535,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["9,790,562 B2"],"award-info":[{"award-number":["9,790,562 B2"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 ES 028615-01"],"award-info":[{"award-number":["R01 ES 028615-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD 087417"],"award-info":[{"award-number":["R01 HD 087417"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD 094378"],"award-info":[{"award-number":["R01 HD 094378"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD 094380"],"award-info":[{"award-number":["R01 HD 094380"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013050","name":"New England Research Institutes","doi-asserted-by":"publisher","award":["P50HS023418"],"award-info":[{"award-number":["P50HS023418"]}],"id":[{"id":"10.13039\/100013050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013050","name":"New England Research Institutes","doi-asserted-by":"publisher","award":["R01HD 60503"],"award-info":[{"award-number":["R01HD 60503"]}],"id":[{"id":"10.13039\/100013050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014932","name":"Ascend Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014932","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ajog.2020.07.032","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T10:41:36Z","timestamp":1595241696000},"page":"72.e1-72.e50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids"],"prefix":"10.1016","volume":"224","author":[{"given":"Ayman","family":"Al-Hendy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte D.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt T.","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Schlaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Puscheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Gillispie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgul","family":"Muneyyirci-Delale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.07.032_bib1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.07.032_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/IJWH.S133212","article-title":"Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis","volume":"9","author":"Fuldeore","year":"2017","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ajog.2020.07.032_bib3","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/jwh.2018.7076","article-title":"Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women","volume":"27","author":"Marsh","year":"2018","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2020.07.032_bib4","doi-asserted-by":"crossref","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","article-title":"Uterine fibroids","volume":"2","author":"Stewart","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajog.2020.07.032_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2217\/whe.15.81","article-title":"Pathophysiology of heavy menstrual bleeding","volume":"12","author":"Hapangama","year":"2016","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.ajog.2020.07.032_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0029-7844(97)00534-6","article-title":"Variation in the incidence of uterine leiomyoma among premenopausal women by age and race","volume":"90","author":"Marshall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/PGP.0b013e3181e8ae64","article-title":"BMI and uterine size: is there any relationship?","volume":"29","author":"Dandolu","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajog.2020.07.032_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0030-1251477","article-title":"New directions in the epidemiology of uterine fibroids","volume":"28","author":"Laughlin","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2020.07.032_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00006250-199404000-00011","article-title":"Hysterectomy in the United States, 1988\u20131990","volume":"83","author":"Wilcox","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0015-0282(98)00208-8","article-title":"A\u00a0prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata","volume":"70","author":"Marshall","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.07.032_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/aje\/kwh016","article-title":"Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study","volume":"159","author":"Wise","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2020.07.032_bib13","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.fertnstert.2011.03.079","article-title":"The FIGO classification of causes of abnormal uterine bleeding in the reproductive years","volume":"95","author":"Munro","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.07.032_bib14","first-page":"431","article-title":"Self-reported heavy bleeding associated with uterine leiomyomata","volume":"101","author":"Wegienka","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2020.07.032_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","article-title":"Uterine leiomyomata: etiology, symptomatology, and management","volume":"36","author":"Buttram","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.07.032_bib17","first-page":"516","article-title":"Sonohysterography in premenopausal women with and without abnormal bleeding","volume":"94","author":"Clevenger-Hoeft","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib18","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","article-title":"Clinical practice. Uterine fibroids","volume":"372","author":"Stewart","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.07.032_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.ede.0000158742.11877.99","article-title":"Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women","volume":"16","author":"Wise","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.ajog.2020.07.032_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/AOG.0000000000002462","article-title":"Ulipristal acetate for treatment of symptomatic uterine leiomyomas: a randomized controlled trial","volume":"131","author":"Simon","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.07.032_bib22","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"Borah","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1056\/NEJMoa1904351","article-title":"Elagolix for heavy menstrual bleeding in women with uterine fibroids","volume":"382","author":"Schlaff","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.07.032_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1933719113497292","article-title":"Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study","volume":"21","author":"Diamond","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2020.07.032_bib25","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1210\/jc.2016-3845","article-title":"Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women","volume":"102","author":"Ng","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2020.07.032_bib26","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.fertnstert.2010.03.061","article-title":"Menstrual blood loss measurement: validation of the alkaline hematin technique for feminine hygiene products containing superabsorbent polymers","volume":"94","author":"Magnay","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2020.07.032_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/03007995.2016.1248382","article-title":"Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire","volume":"33","author":"Coyne","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajog.2020.07.032_bib28","first-page":"290","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/AOG.0000000000003354","article-title":"Short-term health-related quality of life after hysterectomy compared with myomectomy for symptomatic leiomyomas","volume":"134","author":"Nicholson","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib30","doi-asserted-by":"crossref","first-page":"304.e1","DOI":"10.1016\/j.ajog.2014.11.031","article-title":"Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative","volume":"212","author":"Corona","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib31","author":"Raine"},{"key":"10.1016\/j.ajog.2020.07.032_bib32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/AOG.0b013e31820780e3","article-title":"Uterine leiomyomas: individualizing the approach to a heterogeneous condition","volume":"117","author":"Laughlin","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.07.032_bib33","author":"Hartmann"},{"key":"10.1016\/j.ajog.2020.07.032_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/humupd\/2.4.295","article-title":"Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era","volume":"2","author":"Stewart","year":"1996","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2020.07.032_bib35","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/humupd\/dmr031","article-title":"Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications","volume":"17","author":"Ciarmela","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2020.07.032_bib36","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.fertnstert.2008.03.029","article-title":"Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity","volume":"93","author":"Rackow","year":"2010","journal-title":"Fertil Steril"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820307511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820307511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:35:12Z","timestamp":1762079712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820307511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0002937820307511"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.07.032","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AbbVie Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}